EVOLUTE® EXPRESS ABN is a modified PS-DVB polymeric SPE phase for extraction of acidic, basic and neutral analytes. It's unique modified surface structure is water-wettable to promote robust, reliable sample preparation. A balanced combination of polar (hydrophilic) and non-polar (hydrophobic) interactions allows efficient extraction of analytes of wide ranging polarity. Available in a variety of formats, 96-well plates and SPE columns, EVOLUTE EXPRESS ABN is versatile and easy to use for applications ranging from drugs in biological fluids to pharmaceuticals in water.
Part No. | Description | Pack Size | List Price | |
---|---|---|---|---|
600-0010-PX01 | EVOLUTE® EXPRESS ABN 10 mg Fixed Well Plate | 1 | 296 USD | Add to quote/cart |
600-0001-AXG | EVOLUTE® EXPRESS ABN 10 mg/1 mL (Tabless) | 100 | 218 USD | Add to quote/cart |
610-0010-HX | EVOLUTE® EXPRESS ABN 100 mg/10 mL (3 mL XL) | 50 | 217 USD | Add to quote/cart |
610-0010-BXG | EVOLUTE® EXPRESS ABN 100 mg/3 mL (Tabless) | 50 | 233 USD | Add to quote/cart |
610-0015-CXG | EVOLUTE® EXPRESS ABN 150 mg/6 mL (Tabless) | 30 | 182 USD | Add to quote/cart |
600-0030-PX01 | EVOLUTE® EXPRESS ABN 30 mg Fixed Well Plate | 1 | 296 USD | Add to quote/cart |
600-0003-AX | EVOLUTE® EXPRESS ABN 30 mg/1 mL | 100 | 229 USD | Add to quote/cart |
600-0003-AXG | EVOLUTE® EXPRESS ABN 30 mg/1 mL (Tabless) | 100 | 235 USD | Add to quote/cart |
600-0003-AXG-1000 | EVOLUTE® EXPRESS ABN 30 mg/1 mL (Tabless) | 1000 | 2468 USD | Add to quote/cart |
610-0050-CXG | EVOLUTE® EXPRESS ABN 500 mg/6 mL (Tabless) | 30 | 294 USD | Add to quote/cart |
610-0006-BX | EVOLUTE® EXPRESS ABN 60 mg/3 mL | 50 | 160 USD | Add to quote/cart |
610-0006-BXG | EVOLUTE® EXPRESS ABN 60 mg/3 mL (Tabless) | 50 | 160 USD | Add to quote/cart |
Biotage is a Global Impact Tech Company committed to solving society’s problems. We offer workflow solutions and products to customers in drug discovery and development and diagnostics, analytical testing and water and environmental testing.
Biotage is contributing to sustainable science with the goal to make the world healthier, greener and cleaner – HumanKind Unlimited.
Our customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research and contract manufacturers as well as clinical, forensic and academic laboratories in addition to organizations focused on food safety, clean water and environmental sustainability.
Biotage is headquartered in Uppsala in Sweden and employs appr. 700 people worldwide. The Group had sales of 1,566 MSEK in 2022 and our products are sold in more than 80 countries. Biotage’s share (BIOT) is listed in the Large Cap segment on the NASDAQ Stockholm.
Copyright © 2023 Biotage